Henry Schein

HSIC · NASDAQ

$84.68+$0.71 (+0.85%)TodayMarket closed · Oct 20, 5:46 PM ET

Prev close $83.97

About HSIC

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. The company is headquartered in Melville, New York and currently employs 25,000 full-time employees. Its segments consist of Global Distribution and Value-Added Services, Global Specialty Products and Global Technology. Global Distribution and Value-Added Services include distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other practice services. This segment also markets and sells, under its own corporate brand, a portfolio of consumable merchandise. Global Specialty Products includes manufacturing, marketing and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products and other health care-related products and services. Global Technology includes development and distribution of practice management software, e-services, and other products.

Employees: 25,000
Headquarters: Melville, New York
Listed: Nov 3, 1995
Sector: Health Care
Industry: Health Care Providers & Services
Website: henryschein.com

Leadership

Henry Schein executives
Name	Title	Since	Age
Stanley Bergman	—	1980	75
Ronald South	—	—	63
Andrea Albertini	—	—	55
R. Boggan	—	—	60
Thomas Popeck	—	—	56
Bianka Wilson	—	—	57
Michael Ettinger	—	—	64
Christine Sheehy	—	—	57
Mark Mlotek	—	1994	69
Christopher Pendergast	—	—	62
Kelly Murphy	—	—	44
David Kochman	—	—	45
James Mullins	—	—	60
Walter Siegel	—	—	65
Philip Laskawy	—	—	84
Mohamad Ali	—	—	54
William Daniel	—	—	60
Deborah Derby	—	—	61
Carole Faig	—	—	63
Joseph Herring	—	—	69
Robert Hombach	—	—	59
Kurt Kuehn	—	—	70
Max Lin	—	—	44
Anne Margulies	—	—	69
Scott Serota	—	—	68
Bradley Sheares	—	—	68
Reed Tuckson	—	—	74
Graham Stanley	—	2021	—

Revenue by product and region

Fiscal year ended Dec 28, 2024: $12.67B total revenue

By product

Global Distribution and Value-Added Services [Member]$10.73B84.7%
Global Specialty Products [Member]$1.31B10.4%
Global Technology [Member]$630.00M5.0%

By region

UNITED STATES$8.80B69.5%
Locations Other Than United States [Member]$3.87B30.5%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Henry Schein suppliers and customers
Company	Relationship	Country	Correlation
Envista Holdings NVST	Supplier	US	0.62
Merck & Co., Inc. MRK	Supplier	US	0.49
Zhejiang Gongdong Medical Technology A	Supplier	CN	0.48
Pfizer Inc. PFE	Supplier	US	0.25
Eagle Pharmaceuticals EGRX	Supplier	US	-0.04
United Parcel Service B UPS	Supplier and customer	US	-0.16
Grifols A GRF.MC	Supplier	ES	-0.36
HansBiomed Corporation	Supplier	KR	-0.39
Swedencare AB (publ) SECARE.ST	Supplier	SE	-0.43
ON24 ONTF	Supplier	US	-0.46

Similar companies

Companies in the same industry as Henry Schein

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.